Sort
39,280 grants matching “leukemia”
Prenatal Exposures & Procarcinogenic Mutations
$335,087Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2007 · ES
Biology of Imatinib-Resistant Mutants of BCR-ABL
$335,062Michael W Deininger · Oregon Health & Science University · R01 · FY2006 · HL
Characterization of ERK8, a new MAPK in Lung
$335,062Mark K Abe · University Of Chicago · R01 · FY2006 · HL
Targeting Acid Ceramidase in AML
$335,061Thomas P Loughran · University Of Virginia · P01 · FY2021 · CA
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
$335,016Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2021 · AR
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
$335,016Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2023 · AR
Gradient Biomaterials to Investigate Niche Regulation of Hematopoiesis
$335,015Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2017 · DK
Targeted Therapy for t(8;21)+ AML
$335,013Stephen David Nimer · University Of Miami School Of Medicine · R01 · FY2019 · CA
Clinical Significance of MHC Haplotypes in HCT
$335,005Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Principal Project-Characterization of ANA+ and ANA-B cells in individuals with SLE and healthy subjects
$335,000Betty Diamond · Feinstein Institute For Medical Research · U19 · FY2025 · AI
Clinical Significance of MHC Haplotypes in HCT
$334,986Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
REGULATION OF GLUCOCORTICOID RECEPTOR BY PHOSPHORYLATION
$334,978New York University School Of Medicine · R01 · FY2002 · DK
Clinical Significance of MHC Haplotypes in HCT
$334,967Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
CCR-Frederick Flow Cytometry Core
$334,964Jeffrey Carrell · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Cellular Imaging and Molecular Pathology
$334,956Christopher H Contag · Stanford University · P01 · FY2009 · CA
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
$334,950Shobha Vasudevan · Massachusetts General Hospital · R01 · FY2016 · GM
Biological functions and mechanisms of action of Ikaros proteins
$334,950Stephen T Smale · University Of California Los Angeles · R01 · FY2012 · DK
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
$334,950Shobha Vasudevan · Massachusetts General Hospital · R01 · FY2019 · GM
Biological functions and mechanisms of action of Ikaros proteins
$334,950Stephen T Smale · University Of California Los Angeles · R01 · FY2014 · DK
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
$334,950Shobha Vasudevan · Massachusetts General Hospital · R01 · FY2015 · GM
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
$334,950Shobha Vasudevan · Massachusetts General Hospital · R01 · FY2017 · GM
Post-transcriptional Gene Expression of the TNF alpha by an FXR1a-associated microRNP
$334,950Shobha Vasudevan · Massachusetts General Hospital · R01 · FY2018 · GM
Genomics of Teatment-Related AML
$334,941Daniel C Link · Washington University · P01 · FY2013 · CA
WUMC-Cancer and Leukemia Group B
$334,932Nancy L Bartlett · Washington University · U10 · FY2008 · CA
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy
$334,901Robert Lowsky · Stanford University · P01 · FY2023 · CA